172 related articles for article (PubMed ID: 12960655)
21. A contraction response of the internal anal sphincter to Botulinum toxin: does low-pressure chronic anal fissure have a different pathophysiology?
Lindsey I; Jones OM; Cunningham C
Colorectal Dis; 2011 Sep; 13(9):1014-8. PubMed ID: 20478002
[TBL] [Abstract][Full Text] [Related]
22. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353
[TBL] [Abstract][Full Text] [Related]
23. Role of rectal biopsy in predicting response to intrasphincteric botulinum toxin injection for obstructive symptoms after a pullthrough operation.
Hosseini SM; Foroutan HR; Bahador A; Khosravi MB; Geramizadeh B; Sabet B; Zeraatian S; Razmi T; Banani SJ
Indian J Gastroenterol; 2008; 27(3):99-102. PubMed ID: 18787278
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.
Wester T; Granström AL
Pediatr Surg Int; 2015 Mar; 31(3):255-9. PubMed ID: 25616563
[TBL] [Abstract][Full Text] [Related]
25. Thickening of the internal anal sphincter in idiopathic constipation in children.
Keshtgar AS; Ward HC; Clayden GS; Sanei A
Pediatr Surg Int; 2004 Dec; 20(11-12):817-23. PubMed ID: 15452728
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type-A injection to treat patients with intractable anismus unresponsive to simple biofeedback training.
Zhang Y; Wang ZN; He L; Gao G; Zhai Q; Yin ZT; Zeng XD
World J Gastroenterol; 2014 Sep; 20(35):12602-7. PubMed ID: 25253964
[TBL] [Abstract][Full Text] [Related]
27. Treatment of proctalgia fugax with botulinum A toxin.
Katsinelos P; Kalomenopoulou M; Christodoulou K; Katsiba D; Tsolkas P; Pilpilidis I; Papagiannis A; Kapitsinis I; Vasiliadis I; Souparis T
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1371-3. PubMed ID: 11692065
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
Minkes RK; Langer JC
J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial: effects of botulinum toxin on Levator ani syndrome--a double-blind, placebo-controlled study.
Rao SS; Paulson J; Mata M; Zimmerman B
Aliment Pharmacol Ther; 2009 May; 29(9):985-91. PubMed ID: 19222415
[TBL] [Abstract][Full Text] [Related]
30. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
Menteş BB; Irkörücü O; Akin M; Leventoğlu S; Tatlicioğlu E
Dis Colon Rectum; 2003 Feb; 46(2):232-7. PubMed ID: 12576897
[TBL] [Abstract][Full Text] [Related]
31. Cricopharyngeal achalasia in children: botulinum toxin injection as a tool for diagnosis and treatment.
Scholes MA; McEvoy T; Mousa H; Wiet GJ
Laryngoscope; 2014 Jun; 124(6):1475-80. PubMed ID: 24122834
[TBL] [Abstract][Full Text] [Related]
32. Neurostimulation-guided Anal Intrasphincteric Botulinum Toxin Injection in Children With Hirschsprung Disease.
Louis-Borrione C; Faure A; Garnier S; Guys JM; Merrot T; Héry G; Dariel A
J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):527-532. PubMed ID: 30444834
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type-A in therapy of patients with anismus.
Ron Y; Avni Y; Lukovetski A; Wardi J; Geva D; Birkenfeld S; Halpern Z
Dis Colon Rectum; 2001 Dec; 44(12):1821-6. PubMed ID: 11742168
[TBL] [Abstract][Full Text] [Related]
34. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study.
Roorda D; Oosterlaan J; van Heurn E; Derikx J
J Pediatr Surg; 2021 Aug; 56(8):1342-1348. PubMed ID: 33288128
[TBL] [Abstract][Full Text] [Related]
35. EUS-guided botulinum toxin injection of the internal anal sphincter in anorectal outlet obstruction.
Trindade AJ; Hirten R; Greenberg RE; Sejpal DV
Am J Gastroenterol; 2014 Aug; 109(8):1293-4. PubMed ID: 25091252
[No Abstract] [Full Text] [Related]
36. Anorectal manometry with and without ketamine for evaluation of defecation disorders in children.
Keshtgar AS; Choudhry MS; Kufeji D; Ward HC; Clayden GS
J Pediatr Surg; 2015 Mar; 50(3):438-43. PubMed ID: 25746704
[TBL] [Abstract][Full Text] [Related]
37. [Morphological characteristic of anal canal in patients with dyssynergic defecation and its correlation with anorectal manometry].
Xue YY; Ding YJ; Jiang B; Ding SQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):457-463. PubMed ID: 31104432
[No Abstract] [Full Text] [Related]
38. Comparison of botulinium toxin injection and posterior anorectal myectomy in treatment of internal anal sphincter achalasia.
Foroutan HR; Hosseini SM; Banani SA; Bahador A; Sabet B; Zeraatian S; Banani SJ
Indian J Gastroenterol; 2008; 27(2):62-5. PubMed ID: 18695305
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of botulinum toxin on the internal anal sphincter.
Jones OM; Brading AF; Mortensen NJ
Br J Surg; 2004 Feb; 91(2):224-8. PubMed ID: 14760672
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of botulinum toxin for the treatment of chronic anal fissure: prospective clinical and manometric study.
Arroyo A; Perez F; Serrano P; Candela F; Calpena R
Int J Colorectal Dis; 2005 May; 20(3):267-71. PubMed ID: 15526113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
